Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 10 EP applications David Christopher Holland has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13817826

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

IPC classification:
A61K 45/06, A61K 31/496, A61K 31/343, A61K 31/31, A61P 43/00, A61P 5/00
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Agent:
Appleyard Lees Ltd
Status:
GRANT OF PATENT INTENDED
EP16753172

DERIVATIVES OF SOBETIROME

IPC classification:
A61P 25/00, A61K 31/397, A61K 31/221, A61K 31/216, C07D 205/04, C07C 59/48
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16756142

METHOD FOR SOLUTION PHASE DETRITYLATION OF OLIGOMERIC COMPOUNDS

IPC classification:
C12P 19/34
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16793266

CORTISTATIN ANALOGUES, SYNTHESES, AND USES THEREOF

IPC classification:
A61K 31/4725, C07D 493/08, A61K 31/517
Applicant:
Harvard College
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16793249

TARGETED SELECTION OF PATIENTS FOR TREATMENT WITH CORTISTATIN DERIVATIVES

IPC classification:
C07D 493/22, C07D 493/08, A61P 35/04, A61P 35/02, A61P 35/00
Applicant:
Harvard College
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16797277

METHODS TO PREVENT TISSUE COLONIZATION OF PATHOGENS AND FOR TREATMENT OF BIOFILMS ON ANIMAL TISSUES

IPC classification:
A01N 25/22, A01N 31/08, A01N 31/16
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16818724

MODIFIED CRISPR RNA AND MODIFIED SINGLE CRISPR RNA AND USES THEREOF

IPC classification:
C07H 19/00, A61K 31/7088, C12N 15/63, C12N 9/22
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16818816

CORTISTATIN ANALOGUES AND SYNTHESES AND USES THEREOF

IPC classification:
C07D 493/08, A61K 31/4725, A61K 31/517
Applicant:
Harvard College
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17202158

OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF

IPC classification:
C12N 15/11, C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
The application has been published
EP16782374

RATIONAL COMBINATION THERAPY FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/704, A61K 31/52, A61K 31/337, A61K 45/06
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
David Christopher Holland, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature